SOM Biotech attended the BIO International Convention 2020 in its virtual format “BIO Digital” on June 8th – 12th.

The virtual gathering, one of the most relevant venues for the biotech industry worldwide, allowed SOM biotech to hold more than 70 meetings with key potential business partners and identify opportunities for future drug discovery and development projects.

Raul Insa, CEO of SOM Biotech: “We have shared with potential partners details on the latest developments of our pipeline, and especially the positive results obtained, among others, from the clinical trials related to SOM3355 for Chorea in Huntington’s disease. The recently developed program for three COVID-19 compounds has also drawn a lot of interest from pharmaceutical companies, as well as the opportunities for partnerships that may arise from taking advantage of SOM Biotech´s proprietary AI- drug discovery technology, allowing to optimize and speed the identification of potential drug candidates for specific indications”.

BIO International Convention 2020

SUBCRIBE TO OUR NEWSLETTER

    Name*
    Email*


    I confirm that by completing this form I have used only personal data about myself and that they are true and up-to-date.
    SOM INNOVATION BIOTECH, S.A. is responsible for the processing of my personal data to manage the newsletter service requested through the form, as well as to track the receipt of these through tracking technologies. The Privacy Policy tells me how I can exercise my rights of access, rectification, deletion, limitation, portability and opposition.